In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants
- PMID: 6763003
In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants
Abstract
Lymphocytes from peripheral blood were isolated from leprosy patients and healthy contacts (HC) of leprosy patients and stimulated in vitro with: Mycobacterium leprae and a M. leprae cell wall antigen, MLW 1; tuberculin purified protein derivative (PPD); antigens prepared from Candida albicans, Entamoeba histolytica, Leishmania aethiopica, and parotitis virus; the non-specific mitogens phytohemagglutinin (PHA) and concanavalin A (Con-A). Lymphocytes from patients with untreated lepromatous leprosy failed to respond to the M. leprae antigens, and the median response to PPD was also significantly (p less than 0.005) lower than in the HC group. They responded almost as well as the other groups to non-mycobacterial antigens, PHA, and Con-A. In LL patients who had been treated with dapsone for several (median 10) years, the failure to respond to M. leprae antigens remained, but the depression of the PPD response and the slight non-specific depression of the lymphocyte stimulation test (LST) responsiveness had been reversed. Our results confirm that the major defect in the cell-mediated immune response of LL patients is M. leprae-specific and permanent. The possibility that the defect may be due to a continuous, antigen-induced suppression of the immune response is discussed. That the defect also affected the response to PPD is important since it points to a clear antigenic relationship between M. leprae and BCG/M. tuberculosis. Evidence is presented suggesting that an antigen induced suppressor mechanism may be operating in vitro with cells from patients with borderline tuberculoid leprosy.
Similar articles
-
M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.J Immunol. 1986 Jun 1;136(11):4255-63. J Immunol. 1986. PMID: 2422278
-
T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.Eur J Immunol. 1989 Apr;19(4):707-13. doi: 10.1002/eji.1830190421. Eur J Immunol. 1989. PMID: 2659369
-
Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):51-8. Int J Lepr Other Mycobact Dis. 1993. PMID: 8326181
-
The immunobiology of leprosy.Int Rev Exp Pathol. 1986;28:45-78. Int Rev Exp Pathol. 1986. PMID: 3516911 Review.
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
Cited by
-
Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans.Clin Dev Immunol. 2013;2013:320168. doi: 10.1155/2013/320168. Epub 2013 Jan 21. Clin Dev Immunol. 2013. PMID: 23401696 Free PMC article.
-
In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.Clin Exp Immunol. 1984 Aug;57(2):315-23. Clin Exp Immunol. 1984. PMID: 6380833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical